Virtual Evolution: A Conference for Women by Women


 

59 y/o Woman With HER2+ Invasive Ductal Carcinoma Who Received 6 Cycles of Neoadjuvant TCHP: Which Post-Neoadjuvant Systemic Option to Consider? What Are RT Options?

15 views
December 8, 2020
0 Comments
Login to view comments. Click here to Login